Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	6-phosphofructokinase activity	PFKL PFKM	1.02e-04	3	117	2	GO:0003872
GeneOntologyBiologicalProcess	glycolytic process through glucose-6-phosphate	GALE FOXK2 PFKL PFKM	1.13e-05	25	117	4	GO:0061620
GeneOntologyBiologicalProcess	epithelium development	FLG FLNB ABL1 CEBPA KRT19 COL27A1 PDZD7 RIPK4 SIPA1 TEK KRT23 ESRP2 FOXP4 FASN SALL2 MEGF8 ZFP36L1 TMEM132E PKP3 PKHD1 NUMB FOXP3	2.37e-05	1469	117	22	GO:0060429
GeneOntologyBiologicalProcess	glycolytic process through fructose-6-phosphate	GALE FOXK2 PFKL PFKM	2.75e-05	31	117	4	GO:0061615
GeneOntologyBiologicalProcess	epithelial cell differentiation	FLG FLNB ABL1 CEBPA KRT19 COL27A1 PDZD7 SIPA1 KRT23 FOXP4 FASN ZFP36L1 TMEM132E PKHD1 NUMB FOXP3	3.26e-05	870	117	16	GO:0030855
GeneOntologyCellularComponent	6-phosphofructokinase complex	PFKL PFKM	9.28e-05	3	117	2	GO:0005945
Domain	6-Pfructokinase_euk	PFKL PFKM	1.14e-04	3	116	2	IPR009161
Domain	PHOSPHOFRUCTOKINASE	PFKL PFKM	1.14e-04	3	116	2	PS00433
Domain	Phosphofructokinase_CS	PFKL PFKM	1.14e-04	3	116	2	IPR015912
Domain	PFK	PFKL PFKM	1.14e-04	3	116	2	PF00365
Domain	ATP_PFK	PFKL PFKM	1.14e-04	3	116	2	IPR022953
Domain	Phosphofructokinase_dom	PFKL PFKM	1.14e-04	3	116	2	IPR000023
Domain	FOXP-CC	FOXP4 FOXP3	2.28e-04	4	116	2	PF16159
Domain	FOXP-CC	FOXP4 FOXP3	2.28e-04	4	116	2	IPR032354
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FOXK2 ABL1 ZNF48 LPAR5 KIF26A BICRA EMID1 GRIN2D MDFI FAAP100 ADGRA2 CIC ZNF503 ESRP2 JUNB FASN CELSR3 MEGF8 ARAP1 BAHCC1	1.16e-09	1105	119	20	35748872
Pubmed	Regulatory T-cells and micrometastasis in lymph nodes of stage I NSCLC.	KRT19 FOXP3	1.16e-05	2	119	2	25503147
Pubmed	Insulin specifically regulates expression of liver and muscle phosphofructokinase isoforms.	PFKL PFKM	1.16e-05	2	119	2	29655163
Pubmed	Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune Diabetes.	ABL1 ERN1	1.16e-05	2	119	2	28380378
Pubmed	Isozyme analysis of human polymorphonuclear leukocyte phosphofructokinase from insulin resistant individuals.	PFKL PFKM	1.16e-05	2	119	2	8780720
Pubmed	Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase.	ABL1 GRIN2D	1.16e-05	2	119	2	10777567
Pubmed	The molecular mechanism of the inherited phosphofructokinase deficiency associated with hemolysis and myopathy.	PFKL PFKM	1.16e-05	2	119	2	6444532
Pubmed	Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.	KRT19 FOXP3	1.16e-05	2	119	2	32606302
Pubmed	Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility.	GRIN2C GRIN2D	1.16e-05	2	119	2	29317596
Pubmed	NMDA GluN2C/2D receptors contribute to synaptic regulation and plasticity in the anterior cingulate cortex of adult mice.	GRIN2C GRIN2D	1.16e-05	2	119	2	33766086
Pubmed	Regulatory T cells sense effector T-cell activation through synchronized JunB expression.	JUNB FOXP3	1.16e-05	2	119	2	31017652
Pubmed	In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons.	GRIN2C GRIN2D	1.16e-05	2	119	2	29651654
Pubmed	Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes.	GRIN2C GRIN2D	1.16e-05	2	119	2	31110197
Pubmed	Enhanced function of NR2C/2D-containing NMDA receptor in the nucleus accumbens contributes to peripheral nerve injury-induced neuropathic pain and depression in mice.	GRIN2C GRIN2D	1.16e-05	2	119	2	35057644
Pubmed	SIRT3 promotes the invasion and metastasis of cervical cancer cells by regulating fatty acid synthase.	SIRT3 FASN	1.16e-05	2	119	2	31677030
Pubmed	NMDA receptors containing GluN2C and GluN2D subunits have opposing roles in modulating neuronal oscillations; potential mechanism for bidirectional feedback.	GRIN2C GRIN2D	1.16e-05	2	119	2	31786200
Pubmed	The glycolytic enzyme phosphofructokinase-1 assembles into filaments.	PFKL PFKM	1.16e-05	2	119	2	28646105
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	BICRA APC2 DDN CIC PLCH2 NUMB IRF2BPL MAML2 ARAP1	1.81e-05	430	119	9	35044719
Pubmed	Chemokine co-receptor CCR5/CXCR4-dependent modulation of Kv2.1 channel confers acute neuroprotection to HIV-1 glycoprotein gp120 exposure.	GRIN2C GRIN2D KCNB1	2.56e-05	17	119	3	24086760
Pubmed	Gene structure and chromosomal localization of the mouse NMDA receptor channel subunits.	ABL1 GRIN2C GRIN2D	3.07e-05	18	119	3	9011744
Pubmed	Auditory pathway and auditory brainstem response in mice lacking NMDA receptor epsilon 1 and epsilon 4 subunits.	GRIN2C GRIN2D	3.47e-05	3	119	2	9718984
Pubmed	Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.	PFKL PFKM	3.47e-05	3	119	2	7825568
Pubmed	Bcr/Abl P190 interaction with Spa-1, a GTPase activating protein for the small GTPase Rap1.	ABL1 SIPA1	3.47e-05	3	119	2	18813851
Pubmed	Isozymes of human phosphofructokinase: identification and subunit structural characterization of a new system.	PFKL PFKM	3.47e-05	3	119	2	6444721
Pubmed	Genomic organization, 5'flanking region and tissue-specific expression of mouse phosphofructokinase C gene.	PFKL PFKM	3.47e-05	3	119	2	11137296
Pubmed	JunB regulates homeostasis and suppressive functions of effector regulatory T cells.	JUNB FOXP3	3.47e-05	3	119	2	30559442
Pubmed	Sirt1 induction confers resistance to etoposide-induced genotoxic apoptosis in thyroid cancers.	SIRT3 FOXP3	3.47e-05	3	119	2	25109285
Pubmed	c-Abl-mediated tyrosine phosphorylation of JunB is required for Adriamycin-induced expression of p21.	ABL1 JUNB	3.47e-05	3	119	2	26217035
Pubmed	Reciprocal effects of C/EBPalpha and PKCdelta on JunB expression and monocytic differentiation depend upon the C/EBPalpha basic region.	CEBPA JUNB	3.47e-05	3	119	2	12522006
Pubmed	JunB and c-Rel cooperatively enhance Foxp3 expression during induced regulatory T cell differentiation.	JUNB FOXP3	3.47e-05	3	119	2	21371435
Pubmed	Phosphofructokinase isozyme expression during myoblast differentiation.	PFKL PFKM	3.47e-05	3	119	2	2521854
Pubmed	Biochemical and transcript level differences between the three human phosphofructokinases show optimisation of each isoform for specific metabolic niches.	PFKL PFKM	3.47e-05	3	119	2	33141153
Pubmed	Cocaine preference and neuroadaptations are maintained by astrocytic NMDA receptors in the nucleus accumbens.	GRIN2C GRIN2D	3.47e-05	3	119	2	35867797
Pubmed	Phosphofructokinase (PFK) isozymes in man. I. Studies of adult human tissues.	PFKL PFKM	3.47e-05	3	119	2	156693
Pubmed	Isozymes of human phosphofructokinase in blood cells and cultured cell lines: molecular and genetic evidence for a trigenic system.	PFKL PFKM	3.47e-05	3	119	2	6451249
Pubmed	Facilitation of GluN2C-containing NMDA receptors in the external globus pallidus increases firing of fast spiking neurons and improves motor function in a hemiparkinsonian mouse model.	GRIN2C GRIN2D	3.47e-05	3	119	2	33421565
Pubmed	Localization of the human NMDAR2D receptor subunit gene (GRIN2D) to 19q13.1-qter, the NMDAR2A subunit gene to 16p13.2 (GRIN2A), and the NMDAR2C subunit gene (GRIN2C) to 17q24-q25 using somatic cell hybrid and radiation hybrid mapping panels.	GRIN2C GRIN2D	3.47e-05	3	119	2	9480759
Pubmed	Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII.	PFKL PFKM	3.47e-05	3	119	2	2960695
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	PFKL FOXP4 FASN CLK3 ACIN1 IRF2BPL RBM34 FOXP3	4.28e-05	370	119	8	22922362
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CASC3 FLNB FOXK2 BICRA PFKL TARS2 MAP3K12 DENND2B CASK FOXP4 PTPN13 PKP3 NUMB C1orf159 TMEM143 ARAP1	4.95e-05	1489	119	16	28611215
Pubmed	Regulation of positive and negative selection and TCR signaling during thymic T cell development by capicua.	CIC FOXP3	6.93e-05	4	119	2	34895467
Pubmed	The Bcr-Abl kinase regulates the actin cytoskeleton via a GADS/Slp-76/Nck1 adaptor protein pathway.	ABL1 GRAP2	6.93e-05	4	119	2	20079431
Pubmed	IRE1α drives lung epithelial progenitor dysfunction to establish a niche for pulmonary fibrosis.	ERN1 KRT19	6.93e-05	4	119	2	35170357
Pubmed	Identification and characterization of T reg-like cells in zebrafish.	FOXP4 FOXP3	6.93e-05	4	119	2	29066577
Pubmed	Activation of extracellular signal-regulated kinase 2 by a novel Abl-binding protein, ST5.	ABL1 DENND2B	6.93e-05	4	119	2	9632734
Pubmed	Structural insights into assembly and function of GluN1-2C, GluN1-2A-2C, and GluN1-2D NMDARs.	GRIN2C GRIN2D	6.93e-05	4	119	2	36309015
Pubmed	PD-1+ memory phenotype CD4+ T cells expressing C/EBPalpha underlie T cell immunodepression in senescence and leukemia.	CEBPA SIPA1	6.93e-05	4	119	2	19805226
Pubmed	Functional correlation of NMDA receptor epsilon subunits expression with the properties of single-channel and synaptic currents in the developing cerebellum.	GRIN2C GRIN2D	6.93e-05	4	119	2	8699248
Pubmed	Role of the carboxy-terminal region of the GluR epsilon2 subunit in synaptic localization of the NMDA receptor channel.	GRIN2C GRIN2D	6.93e-05	4	119	2	9768843
Pubmed	Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs.	FOXK2 RIPK4 JUNB PTPN13 RNF5 CLK3 RBM34	7.49e-05	296	119	7	34186245
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	FLNB SPTLC2 PFKL TARS2 EXOC8 SORCS1 KRT23 PCF11 FASN RNF5	8.01e-05	647	119	10	26618866
Pubmed	Synapse-selective impairment of NMDA receptor functions in mice lacking NMDA receptor epsilon 1 or epsilon 2 subunit.	GRIN2C GRIN2D	1.15e-04	5	119	2	9147327
Pubmed	Heterozygous deletion of NR1 subunit of the NMDA receptor alters ethanol-related behaviors and regional expression of NR2 subunits in the brain.	GRIN2C GRIN2D	1.15e-04	5	119	2	21945132
Pubmed	Roles of the glutamate receptor epsilon2 and delta2 subunits in the potentiation and prepulse inhibition of the acoustic startle reflex.	GRIN2C GRIN2D	1.15e-04	5	119	2	11488959
Pubmed	Differential distributions of the NMDA receptor channel subunit mRNAs in the mouse retina.	GRIN2C GRIN2D	1.15e-04	5	119	2	7510577
Pubmed	Altered expressions and splicing profiles of Acin1 transcripts differentially modulate brown adipogenesis through an alternative splicing mechanism.	ERN1 ACIN1	1.15e-04	5	119	2	32629174
Pubmed	Distinct spatiotemporal distributions of the N-methyl-D-aspartate receptor channel subunit mRNAs in the mouse cervical cord.	GRIN2C GRIN2D	1.15e-04	5	119	2	7929904
Pubmed	Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.	GRIN2C GRIN2D	1.15e-04	5	119	2	26919761
Pubmed	Distinct distributions of five NMDA receptor channel subunit mRNAs in the brainstem.	GRIN2C GRIN2D	1.15e-04	5	119	2	7518475
Pubmed	Distinct spatiotemporal expressions of five NMDA receptor channel subunit mRNAs in the cerebellum.	GRIN2C GRIN2D	1.15e-04	5	119	2	7518474
Pubmed	Neurotransmission and bipolar disorder: a systematic family-based association study.	GRIN2C GRIN2D	1.15e-04	5	119	2	18444252
Pubmed	Distinct gene expression of the N-methyl-D-aspartate receptor channel subunit in peripheral neurons of the mouse sensory ganglia and adrenal gland.	GRIN2C GRIN2D	1.15e-04	5	119	2	8015722
Pubmed	Inducible and reversible NR1 knockout reveals crucial role of the NMDA receptor in preserving remote memories in the brain.	GRIN2C GRIN2D	1.15e-04	5	119	2	15003177
Pubmed	GABAA, GABAC, and NMDA receptor subunit expression in the suprachiasmatic nucleus and other brain regions.	GRIN2C GRIN2D	1.15e-04	5	119	2	7723623
Pubmed	Determination of the genomic structure and mutation screening in schizophrenic individuals for five subunits of the N-methyl-D-aspartate glutamate receptor.	GRIN2C GRIN2D	1.15e-04	5	119	2	12082569
Pubmed	Developmental changes in distribution of NMDA receptor channel subunit mRNAs.	GRIN2C GRIN2D	1.15e-04	5	119	2	1493227
Pubmed	N-methyl-D-aspartic acid receptor structure and function.	GRIN2C GRIN2D	1.15e-04	5	119	2	8036251
Pubmed	NMDA receptor activation by HIV-Tat protein is clade dependent.	GRIN2C GRIN2D	1.15e-04	5	119	2	19020013
Pubmed	Essential role of mitochondrial energy metabolism in Foxp3⁺ T-regulatory cell function and allograft survival.	SIRT3 FOXP3	1.15e-04	5	119	2	25681462
Pubmed	Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.	GRIN2C GRIN2D	1.15e-04	5	119	2	26875626
Pubmed	Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene.	GRIN2C GRIN2D	1.15e-04	5	119	2	8756432
Pubmed	Differential interaction of NMDA receptor subtypes with the post-synaptic density-95 family of membrane associated guanylate kinase proteins.	GRIN2C GRIN2D	1.15e-04	5	119	2	18233995
Pubmed	Capicua deficiency induces autoimmunity and promotes follicular helper T cell differentiation via derepression of ETV5.	CIC FOXP3	1.15e-04	5	119	2	28855737
Pubmed	During embryogenesis, esrp1 expression is restricted to a subset of epithelial cells and is associated with splicing of a number of developmentally important genes.	CASK ESRP2	1.15e-04	5	119	2	23233200
Pubmed	Maternal synchronization of gestational length and lung maturation.	CEBPA TEK FASN	1.64e-04	31	119	3	22096492
Pubmed	A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity.	GRIN2C GRIN2D	1.73e-04	6	119	2	23665428
Pubmed	Altered gene expression of the N-methyl-D-aspartate receptor channel subunits in Purkinje cells of the staggerer mutant mouse.	GRIN2C GRIN2D	1.73e-04	6	119	2	8996814
Pubmed	Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine.	GRIN2C GRIN2D	1.73e-04	6	119	2	25760043
Pubmed	Regulation by afadin of cyclical activation and inactivation of Rap1, Rac1, and RhoA small G proteins at leading edges of moving NIH3T3 cells.	SIPA1 ARAP1	1.73e-04	6	119	2	19589776
Pubmed	Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo.	GRIN2C GRIN2D	1.73e-04	6	119	2	9458051
Pubmed	NMDA receptor GluRepsilon/NR2 subunits are essential for postsynaptic localization and protein stability of GluRzeta1/NR1 subunit.	GRIN2C GRIN2D	1.73e-04	6	119	2	15317856
Pubmed	Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment.	JUNB FOXP3	1.73e-04	6	119	2	33361391
Pubmed	Biochemical analysis of the EJC reveals two new factors and a stable tetrameric protein core.	CASC3 ACIN1	1.73e-04	6	119	2	16314458
Pubmed	Genetic mapping in the mouse of four loci related to the jun family of transcriptional activators.	ABL1 JUNB	2.41e-04	7	119	2	1887331
Pubmed	Early onset of NMDA receptor GluR epsilon 1 (NR2A) expression and its abundant postsynaptic localization in developing motoneurons of the mouse hypoglossal nucleus.	GRIN2C GRIN2D	2.41e-04	7	119	2	12103442
Pubmed	Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures.	GRIN2C GRIN2D	2.41e-04	7	119	2	23267846
Pubmed	Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death.	GRIN2C GRIN2D	2.41e-04	7	119	2	19036954
Pubmed	Genes Frequently Coexpressed with Hoxc8 Provide Insight into the Discovery of Target Genes.	PTPN13 HOXC8	2.41e-04	7	119	2	27025388
Pubmed	HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors.	GRIN2C GRIN2D	2.41e-04	7	119	2	22940423
Pubmed	Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.	GRIN2C GRIN2D	2.41e-04	7	119	2	22833210
Pubmed	CDK5RAP3, a UFL1 substrate adaptor, is crucial for liver development.	CEBPA ERN1 KRT19	2.57e-04	36	119	3	30635284
Pubmed	HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders.	GRIN2C GRIN2D JUNB	3.02e-04	38	119	3	25613138
Pubmed	HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [Ca2+]i increase, alter [Ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons.	GRIN2C GRIN2D	3.21e-04	8	119	2	8563977
Pubmed	Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity.	GRIN2C GRIN2D	3.21e-04	8	119	2	7695237
Pubmed	HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes.	GRIN2C GRIN2D	3.21e-04	8	119	2	17360663
Pubmed	Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120.	GRIN2C GRIN2D	3.21e-04	8	119	2	8724036
Pubmed	Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine.	GRIN2C GRIN2D	3.21e-04	8	119	2	8822372
Pubmed	Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid-ß production.	GRIN2C GRIN2D	3.21e-04	8	119	2	21106831
Pubmed	Glucocorticoid modulation of gp120-induced effects on calcium-dependent degenerative events in primary hippocampal and cortical cultures.	GRIN2C GRIN2D	3.21e-04	8	119	2	10448428
Pubmed	Central nervous system expression of HIV-1 Gp120 activates the hypothalamic-pituitary-adrenal axis: evidence for involvement of NMDA receptors and nitric oxide synthase.	GRIN2C GRIN2D	3.21e-04	8	119	2	8955056
Interaction	TOP3B interactions	FOXK2 ABL1 ZNF48 LPAR5 KIF26A BICRA EMID1 GRIN2D PFKL MDFI FAAP100 ADGRA2 CIC ZNF503 ESRP2 JUNB FASN ERLIN2 CELSR3 MEGF8 RMDN1 ACIN1 ARAP1 BAHCC1	3.20e-06	1470	117	24	int:TOP3B
Cytoband	17q25	FOXK2 GRIN2C FASN	1.45e-04	39	119	3	17q25
Cytoband	11q13	SIPA1 KCNK4 NDUFS8 PCF11	2.62e-04	118	119	4	11q13
Cytoband	Ensembl 112 genes in cytogenetic band chr15q24	ISLR LMAN1L CLK3 STOML1	2.98e-04	122	119	4	chr15q24
Cytoband	Ensembl 112 genes in cytogenetic band chr17q25	FOXK2 GRIN2C FAAP100 FASN BAHCC1	1.27e-03	307	119	5	chr17q25
Cytoband	14q24.3	SPTLC2 NUMB IRF2BPL	1.86e-03	93	119	3	14q24.3
Cytoband	Ensembl 112 genes in cytogenetic band chr14q24	SPTLC2 ZFP36L1 NUMB IRF2BPL	1.88e-03	200	119	4	chr14q24
Cytoband	19q13.33	ODAD1 GRIN2D TMEM143	2.70e-03	106	119	3	19q13.33
GeneFamily	Glutamate ionotropic receptor NMDA type subunits	GRIN2C GRIN2D	4.31e-04	7	83	2	1201
GeneFamily	Ankyrin repeat domain containing	ANKRD13B ANKRD65 RIPK4 ANKZF1 ANKRD53 ARAP1	8.64e-04	242	83	6	403
GeneFamily	Forkhead boxes	FOXK2 FOXP4 FOXP3	1.01e-03	43	83	3	508
Coexpression	PEREZ_TP53_TARGETS	FNIP2 FLG ANKRD65 CEBPA LPAR5 KIF26A COL27A1 APC2 KCP RIPK4 KRT23 ESRP2 JUNB FOXP4 KCNB1 CLK3 IRF2BPL ARAP1	7.10e-06	1201	118	18	M4391
Coexpression	BENPORATH_SUZ12_TARGETS	DCHS2 LINC02875 COL27A1 CDC20B HLX RIPK4 GRIN2D ADGRA2 KCNK4 ZNF503 SORCS1 KL HOXC8 NEUROD2 TMEM132E PODN	1.66e-05	1035	118	16	M9898
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	KRT19 GLB1L3 CYP4B1 RIPK4 PTPN13 SRGAP3 PLCH2	7.24e-07	187	119	7	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	kidney_cells-Hypertensive_with+without-CKD\|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group	KRT19 SPTLC2 ZNF503 PTPN13 SRGAP3 PKHD1 IRF2BPL	7.51e-07	188	119	7	90188b60ff893754f7938fe8edab79758827168e
ToppCell	AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ANKRD65 CEBPA COL27A1 ESRP2 FASN PTPN13 CDCA7	7.78e-07	189	119	7	2d32f09efa982ae458568f6b1cd06bb5078d42a3
ToppCell	facs-Bladder-nan-18m-Epithelial-bladder_urothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT19 EMID1 RIPK4 PFKL MDFI KRT23 PKP3	8.64e-07	192	119	7	18546b4d5e39aafa97186104d47cfda02eb5f4b5
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLG DCHS2 CDC20B VWA7 PKHD1 PODN SH2D7	8.95e-07	193	119	7	315840bc48899f3a36d57b19197509de19716e3d
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KRT19 GLB1L3 RIPK4 MDFI NEUROD2 SRGAP3 PLCH2	1.03e-06	197	119	7	1e915957ea6a4550ecb9d6ee4b232aa5800faf20
ToppCell	LPS_only-Epithelial_alveolar\|LPS_only / Treatment groups by lineage, cell group, cell type	GALE KRT19 CYP4B1 FOXP4 FASN PTPN13 PKP3	1.06e-06	198	119	7	655df75b9692d815c7f6910275e1f684ac63bf62
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	KRT19 CYP4B1 RIPK4 FOXP4 PKP3 PKHD1 CACNA2D3	1.14e-06	200	119	7	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	control-cDC\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FNIP2 ANKRD65 CEBPA ZNF503 FBLN2 SRGAP3 CACNA2D3	1.14e-06	200	119	7	4a6d17a4225be38537d3dd8a39512051f597f4e0
ToppCell	distal-Epithelial-Basal\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FLG KRT19 GLB1L3 CYP4B1 MDFI PKP3 PNLIPRP3	1.14e-06	200	119	7	5c14f0c09bb8b3daf6d649032e888a7880c52b73
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KRT19 GLB1L3 CYP4B1 RIPK4 MDFI PKP3 PLCH2	1.14e-06	200	119	7	0594ca7bc313b73e1dc800cf058f8f798b0284cb
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tregs\|GI_large-bowel / Manually curated celltypes from each tissue	DENND2B KL PTPN13 PKHD1 DNAH6 FOXP3	4.93e-06	162	119	6	9a5e65c45f73a6a685b8362aa2e6aea77181caa3
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	FLNB MDFI ZNF503 SORCS1 SLC4A10 BAHCC1	5.67e-06	166	119	6	773673a5d0430640439845b264740bfbbdad0cb2
ToppCell	10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3\|GI_small-bowel / Manually curated celltypes from each tissue	EMID1 MDFI ZNF503 SORCS1 KL SLC4A10	6.49e-06	170	119	6	97df5ffb328196c46568975d2d97722bcc753bf5
ToppCell	droplet-Marrow-nan-18m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXK2 POT1 MDFI TARS2 MEGF8 BAHCC1	7.42e-06	174	119	6	55cc8300489d11322724159ec7d0e1d32a702e91
ToppCell	facs-Marrow-T_cells-18m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP4B1 PTPN13 ZFP36L1 GRAP2 IRF2BPL FOXP3	7.66e-06	175	119	6	d3d574962c0a4a0d64db120320f0d04e11d2c9d8
ToppCell	facs-Marrow-T_cells\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP4B1 PTPN13 ZFP36L1 GRAP2 IRF2BPL FOXP3	7.66e-06	175	119	6	4d77fade9ab87b79ac206d074b0e2ef8930c044e
ToppCell	Control-Epithelial_alveolar-AT_1-AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KRT19 CYP4B1 RIPK4 PKP3 PKHD1 CACNA2D3	8.45e-06	178	119	6	1817bc520f3d23da8c0fa09bba50ae703a820cb1
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26A CYP4B1 ITGA10 MDFI TEK TMEM132E	8.72e-06	179	119	6	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KRT19 CYP4B1 RIPK4 PKP3 PKHD1 CACNA2D3	9.59e-06	182	119	6	cc79e0cc21e2fdc4ef77f052818d27b9f707aec1
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KRT19 CYP4B1 RIPK4 PKP3 PKHD1 CACNA2D3	9.89e-06	183	119	6	274483009b309289e4cb84beedf6806430db6ff6
ToppCell	(7)_Epithelial-H_(AT1)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	ANKRD65 KRT19 GLB1L3 CYP4B1 RIPK4 PLCH2	1.02e-05	184	119	6	1f76b37c265b519171b767a52d48f31f0cdc4a3c
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like\|lymph-node_spleen / Manually curated celltypes from each tissue	ERN1 EMID1 SORCS1 ZFP36L1 SRGAP3 SLC4A10	1.02e-05	184	119	6	d97471a4fe17cba6880ccf1a04cc00c741558124
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3\|lymph-node_spleen / Manually curated celltypes from each tissue	EMID1 ZNF503 SORCS1 ZFP36L1 SRGAP3 SLC4A10	1.02e-05	184	119	6	479e60f76c191253e23699c9dd7ef7efc08c59ad
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL1 C1RL FBLN2 ZFP36L1 PODN CACNA2D3	1.05e-05	185	119	6	9faa35ceb89ccd2979072286f063687c9f846ce3
ToppCell	facs-Skin-nan-24m-Mesenchymal\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT4 C1RL ISLR FBLN2 SRGAP3 PODN	1.05e-05	185	119	6	8433a337625ff8398520e223ef92bf9bb0beb14c
ToppCell	facs-Skin-nan-24m-Mesenchymal-fibroblast\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT4 C1RL ISLR FBLN2 SRGAP3 PODN	1.05e-05	185	119	6	049d793d043d5d434f143025de49dd210d18756c
ToppCell	facs-Skin-nan-24m-Mesenchymal-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT4 C1RL ISLR FBLN2 SRGAP3 PODN	1.05e-05	185	119	6	63200c42565eea596f9b00728e70e544b8d50a7f
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEBPA MDFI JUNB FOXP4 ZFP36L1 PLCH2	1.08e-05	186	119	6	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYP4B1 RIPK4 FOXP4 PTPN13 PKHD1 CACNA2D3	1.08e-05	186	119	6	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	droplet-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT19 CYP4B1 RIPK4 KRT23 PKP3 PLCH2	1.12e-05	187	119	6	380c3e0bc73b266718893a3b3ca207ce5fd31883
ToppCell	droplet-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT19 CYP4B1 RIPK4 KRT23 PKP3 PLCH2	1.12e-05	187	119	6	5b3c3c6421efd25c740ae121968b5520bbdc07b2
ToppCell	droplet-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT19 CYP4B1 RIPK4 KRT23 PKP3 PLCH2	1.12e-05	187	119	6	796046ff066a9c3847faa9bf1f8beccd956c01f7
ToppCell	facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT19 CYP4B1 RIPK4 KRT23 ESRP2 PLCH2	1.12e-05	187	119	6	fe9fc21192ede2eea61f419d20ccda254569d0a6
ToppCell	facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT19 CYP4B1 RIPK4 KRT23 ESRP2 PLCH2	1.15e-05	188	119	6	8ffb5394f7b00ea483a5fe4df894d22fda935e5c
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL27A1 EMID1 ITGA10 DENND2B PTPN13 MAML2	1.15e-05	188	119	6	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	facs-Trachea-3m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KRT19 CYP4B1 RIPK4 KRT23 ESRP2 PLCH2	1.15e-05	188	119	6	137ed9958044fab7a13648affb469585d1c48cf6
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CEBPA MDFI JUNB FOXP4 ZFP36L1 PLCH2	1.19e-05	189	119	6	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MDFI VWA7 PCF11 JUNB ZFP36L1 NUMB	1.22e-05	190	119	6	92456f6f7eced6e4c4371f495254a65d061c8d0b
ToppCell	facs-Lung-18m-Epithelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CEBPA KRT19 RIPK4 KRT23 ESRP2 PLCH2	1.34e-05	193	119	6	8e934f127bc763e905c788beabfa867bd559b682
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26A CYP4B1 TEK ADGRA2 ZNF503 KCNB1	1.34e-05	193	119	6	d485634c564b268e344b6a2863c26f6adaec9e38
ToppCell	18-Airway-Epithelial-Basal_cell\|Airway / Age, Tissue, Lineage and Cell class	KRT19 RIPK4 JUNB ZFP36L1 PKP3 PLCH2	1.34e-05	193	119	6	5067b0db24f96e26cf3f9437736415f694e7a614
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KCP AGBL4 PTPN13 SRGAP3 PKHD1 CACNA2D3	1.38e-05	194	119	6	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	AT2\|World / shred by cell class for parenchyma	GALE CEBPA KRT19 FASN PTPN13 TMEM41B	1.38e-05	194	119	6	e773f5ef3abce7113a6b7cc7cbe68de873d4a17f
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLG ANKRD65 KRT19 RIPK4 MDFI KRT23	1.42e-05	195	119	6	dd8117dbd22892288f74a7314ab0b5080106936c
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway-squamous_epithelial_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLG ANKRD65 KRT19 RIPK4 MDFI KRT23	1.42e-05	195	119	6	82d87fdb39ec15be9057e2d2ba5c1afb5f97aafe
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DNAAF9 AGBL4 PTPN13 SRGAP3 PKHD1 CACNA2D3	1.42e-05	195	119	6	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	mild-dn_T\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FLNB LPAR5 CYP4B1 CASK CDCA7 RAB27A	1.42e-05	195	119	6	158f0f229bad71cc9b06b7399168982bbbbd1d47
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	KRT19 GLB1L3 RIPK4 MDFI SRGAP3 PLCH2	1.46e-05	196	119	6	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KCP AGBL4 PTPN13 SRGAP3 PKHD1 CACNA2D3	1.46e-05	196	119	6	6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCP AGBL4 PTPN13 SRGAP3 PKHD1 CACNA2D3	1.46e-05	196	119	6	eea66711a16134f86e6c533a5a837ff2e0d7ca7f
ToppCell	mild_COVID-19-cDC\|World / disease group, cell group and cell class (v2)	FNIP2 ANKRD65 ZNF503 FBLN2 SRGAP3 CACNA2D3	1.50e-05	197	119	6	63e7b040c64f1e28b8db79980c7b580caa7d1b95
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLG KRT19 RIPK4 MDFI KRT23 PKP3	1.50e-05	197	119	6	ac9c0c25cfeaabd53d332982c73fc6c47b0c6478
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLG KRT19 RIPK4 MDFI KRT23 PKP3	1.50e-05	197	119	6	b57d2e3413ef6dd1da56c45087926f2f3eab876c
ToppCell	3'-Broncho-tracheal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KRT19 CYP4B1 RIPK4 MDFI SRGAP3 PKP3	1.50e-05	197	119	6	5d33f8a6940431093e927b186fb9b630a89d8ec1
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KRT19 GLB1L3 CYP4B1 RIPK4 SRGAP3 PLCH2	1.50e-05	197	119	6	de772bd2b4cda843777ac879b1087e6444199dfb
ToppCell	mild_COVID-19-cDC\|mild_COVID-19 / disease group, cell group and cell class (v2)	FNIP2 ANKRD65 ZNF503 FBLN2 SRGAP3 CACNA2D3	1.50e-05	197	119	6	44ebd3f967779bb7753fc6dcd9fde6d682f9ccd6
ToppCell	3'-Broncho-tracheal-Epithelial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KRT19 CYP4B1 RIPK4 MDFI SRGAP3 PKP3	1.55e-05	198	119	6	aa6e7218ee6230902854e66c444b544218b30c0e
ToppCell	LPS_anti-TNF-Epithelial_alveolar\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	GALE KRT19 CYP4B1 FOXP4 PTPN13 PKP3	1.55e-05	198	119	6	53e9ed1b19cb26be58da0f37057caca0cdfaabeb
ToppCell	Biopsy_Control_(H.)-Epithelial-SCGB3A2+\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	KRT19 CYP4B1 COL27A1 ESRP2 PTPN13 ZFP36L1	1.55e-05	198	119	6	1fe51f4beca0eef4ff117e6edaa646e35c0f9629
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	GALE KRT19 CYP4B1 FOXP4 PTPN13 PKP3	1.55e-05	198	119	6	82bcd44f8744e7e8477fbfd871a52f3d1a8b3adc
ToppCell	medial-Epithelial-Basal\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KRT19 GLB1L3 CYP4B1 RIPK4 MDFI PKP3	1.59e-05	199	119	6	fa7584e3cc0f8cbdd6a76c6a0faee26b0922c4ae
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ITGA10 ISLR ADGRA2 ANKRD53 FBLN2 PODN	1.59e-05	199	119	6	dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f
ToppCell	cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KRT19 RIPK4 MDFI SRGAP3 PKP3 PLCH2	1.59e-05	199	119	6	974f71b56f66243c78f2f297a1540e0e186df530
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLX ISLR MDFI ZNF503 ZFP36L1 CACNA2D3	1.59e-05	199	119	6	a95aa72387c9558e0316898eaa9df4de8932af1b
ToppCell	LPS_IL1RA-Epithelial_alveolar\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GALE KRT19 CYP4B1 FOXP4 PTPN13 PKP3	1.59e-05	199	119	6	5b140ac88ebc25ce397ae577e48f3e271faf46e7
ToppCell	medial-Epithelial-Basal-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KRT19 GLB1L3 CYP4B1 RIPK4 MDFI PKP3	1.59e-05	199	119	6	fc37f8868417308fb4410684d0d1e506cec30f35
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLX ISLR MDFI ZNF503 ZFP36L1 CACNA2D3	1.59e-05	199	119	6	bb201deb281619113edcd1de2af2d3eb21b967b8
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-3\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ANKRD13B ISLR TEK FBLN2 HOXC8 PODN	1.59e-05	199	119	6	07b8c33342c62afd9c63ec2d757cfa3ba65d2a98
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GALE KRT19 CYP4B1 FOXP4 PTPN13 PKP3	1.59e-05	199	119	6	bb2e839197b9a44b632c1bb716e48d885a1c8713
ToppCell	medial-2-Epithelial-Basal\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KRT19 GLB1L3 CYP4B1 RIPK4 MDFI PKP3	1.59e-05	199	119	6	10af93596cc6d5da4cf5052707ff5f7fc347dc84
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ITGA10 ISLR ADGRA2 ANKRD53 FBLN2 PODN	1.59e-05	199	119	6	c1760581c34b81d1d92c67500a1c8944e9cc6dad
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KRT19 CYP4B1 RIPK4 MDFI PKP3 PLCH2	1.64e-05	200	119	6	afac850d5a40de0d6f02857cf81a19443d90b1eb
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	GALE KRT19 CYP4B1 FOXP4 PTPN13 PKP3	1.64e-05	200	119	6	c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb
ToppCell	Bronchial-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ANKRD65 KRT19 CYP4B1 RIPK4 PTPN13 PKP3	1.64e-05	200	119	6	d3ee5f79513e2ac02ad3329b59e6290d457c44d2
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL1 CYP4B1 ISLR FBLN2 ZFP36L1 PODN	1.64e-05	200	119	6	db6281b5d4032116310db379d9175d790994c99c
ToppCell	proximal-3-Epithelial-Proximal_Basal\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KRT19 RIPK4 CDCA7 SRGAP3 PKP3 PLCH2	1.64e-05	200	119	6	3a0c84f9a551fc2581ec3693481eada297d83f7b
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	KRT19 CYP4B1 FOXP4 PKP3 PKHD1 CACNA2D3	1.64e-05	200	119	6	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	proximal-Epithelial-Proximal_Basal-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KRT19 RIPK4 CDCA7 SRGAP3 PKP3 PLCH2	1.64e-05	200	119	6	de9aec87c86ad0a1bd5e0737c2aae0ec6f269bca
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related-Oligodendrocyte/OPC\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	ZNF48 KRT19 RMDN1 PODN LIPT2 DNAH6	1.64e-05	200	119	6	4db894cfb80fd1f9e01133f345eefd78edd4bc43
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	ZNF48 KRT19 RMDN1 PODN LIPT2 DNAH6	1.64e-05	200	119	6	d46a19274c2836ce7494790ce513764dedcadc79
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	KRT19 GLB1L3 RIPK4 NEUROD2 SRGAP3 PLCH2	1.64e-05	200	119	6	8827653738a931e4a4545e0c7d75be12bed40740
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	KIF26A EMID1 SORCS1 FBLN2 TMEM132E PODN	1.64e-05	200	119	6	16a3685c41194a0a4a772e4eee372160263480e0
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / Treatment groups by lineage, cell group, cell type	KRT19 CYP4B1 FOXP4 PKP3 PKHD1 CACNA2D3	1.64e-05	200	119	6	9a6ae40f3e17cd44ee5fd73260713b920aa2ea15
ToppCell	Parenchymal-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ANKRD65 KRT19 CYP4B1 FASN PTPN13 PKP3	1.64e-05	200	119	6	4e5b6cb014d9bcb58e13c7511c86c43e27c496e4
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_basal-Suprabasal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KRT19 CYP4B1 RIPK4 KRT23 PKP3 PLCH2	1.64e-05	200	119	6	ce969c958a31145bbfe315a9a865d7900ecc9549
ToppCell	Biopsy_Other_PF-Epithelial-Basal\|Biopsy_Other_PF / Sample group, Lineage and Cell type	KRT19 GLB1L3 CYP4B1 RIPK4 SRGAP3 PLCH2	1.64e-05	200	119	6	7098ae4b0ea8ba607519eaed8577c577530fc2a1
ToppCell	proximal-Epithelial-Proximal_Basal\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KRT19 RIPK4 CDCA7 SRGAP3 PKP3 PLCH2	1.64e-05	200	119	6	ff2afa5c0352c214525129f9ff85afc139fe44d2
ToppCell	distal-2-Epithelial-Basal\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KRT19 GLB1L3 CYP4B1 MDFI ESRP2 PKP3	1.64e-05	200	119	6	9beb128841c50241aa819261f21bf66f881ea125
ToppCell	droplet-Fat-Gat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FOXK2 ADGRA2 FOXP4 HOXC8 TMEM143	2.81e-05	132	119	5	4152529611eeacf0c547e2a134d5b98c45426b13
ToppCell	3'_v3-blood-Lymphocytic_Invariant-Inducer-like-MAIT\|blood / Manually curated celltypes from each tissue	B3GNT4 ERN1 DDN GRIN2C SLC4A10	3.99e-05	142	119	5	1175d4390d204ffa3a2d2fe24486f85d3b639b72
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT\|GI_small-bowel / Manually curated celltypes from each tissue	ITGA10 C1RL PTPN13 CDCA7 SLC4A10	4.71e-05	147	119	5	4ba9a86ab7033688a9a2a2dc84c001a49af835b4
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-Trm_Th1/Th17\|blood / Manually curated celltypes from each tissue	ERN1 CASK PTPN13 CDCA7 SLC4A10	5.69e-05	153	119	5	d09bc7322b59f613d66673359ee6af1aea99ce87
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYP4B1 ODAD1 KL SALL2 STOML1	5.87e-05	154	119	5	dcbc6705e91ec744801b621e5d0733a78a7a90ca
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TEK CASK SORCS1 FBLN2 KCNB1	6.06e-05	155	119	5	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KRT19 CYP4B1 RIPK4 PKP3 PKHD1	6.43e-05	157	119	5	9665a1375cfd8e9b8781c852686591226c0e0d9a
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ANKRD65 GDPD3 ZNF503 KCNB1 CACNA2D3	6.43e-05	157	119	5	f896997490bb2eec598c6581f161220e70f9a991
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ANKRD65 GDPD3 ZNF503 KCNB1 CACNA2D3	6.43e-05	157	119	5	14a8516346a89a89f1119b744625bd9844a74a03
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_TIP\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ISLR MDFI KL FBLN2 PODN	6.83e-05	159	119	5	cb2470b288c13e454a2a80115b0d5613b3f718e6
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	LILRB2 HLX ADGRA2 FBLN2 SLC4A10	7.04e-05	160	119	5	c9fe3438f747e2a98e3f27a56ba4c12a3789c2f2
Drug	MCI-176	CASC3 PFKM GRAP2	4.68e-06	7	118	3	CID000063181
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	CEBPA BICRA RIPK4 MAP3K12 ESRP2 JUNB ZFP36L1 BAHCC1	7.61e-06	193	118	8	864_DN
Drug	3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A	ERN1 SPTLC2 ITGA10 SIRT3 HOXC8 ZFP36L1 STOML1 RBM34	8.52e-06	196	118	8	5624_DN
Drug	Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; HL60; HT_HG-U133A	SPTLC2 ITGA10 DDN MAP3K12 CASK ZFP36L1 STOML1 C1orf159	8.84e-06	197	118	8	2972_DN
Drug	S(-)-terguride hydrogen maleate [37686-85-4]; Up 200; 8.8uM; HL60; HT_HG-U133A	SPTLC2 BICRA GDPD3 DDN CASK SALL2 PKP3 ARAP1	9.52e-06	199	118	8	3096_UP
Disease	Intellectual Disability	GALE APC2 GRIN2D CIC KCNK4 FASN ERLIN2 SRGAP3 SLC4A10 ACIN1	1.12e-05	447	116	10	C3714756
Disease	complex cortical dysplasia with other brain malformations (is_implicated_in)	KIF26A APC2	9.15e-05	4	116	2	DOID:0090131 (is_implicated_in)
Disease	specific developmental disorder (implicated_via_orthology)	FOXP4 FOXP3	9.15e-05	4	116	2	DOID:0060038 (implicated_via_orthology)
Disease	glycogen storage disease (implicated_via_orthology)	PFKL PFKM	9.15e-05	4	116	2	DOID:2747 (implicated_via_orthology)
Disease	Mental Retardation, Psychosocial	CIC FASN ERLIN2 SRGAP3 SLC4A10	2.28e-04	139	116	5	C0025363
Disease	Profound Mental Retardation	CIC FASN ERLIN2 SRGAP3 SLC4A10	2.28e-04	139	116	5	C0020796
Disease	Mental deficiency	CIC FASN ERLIN2 SRGAP3 SLC4A10	2.28e-04	139	116	5	C0917816
Disease	octanoylcarnitine measurement	FNIP2 COL27A1	5.42e-04	9	116	2	EFO_0021042
Disease	Pathological accumulation of air in tissues	CEBPA KL	9.86e-04	12	116	2	C0013990
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	PDZD7 TMEM132E	1.16e-03	13	116	2	C1846647
Disease	revision of total hip arthroplasty	RIPK4 VWA7	1.35e-03	14	116	2	EFO_0020973
Disease	colorectal cancer (is_implicated_in)	ABL1 POT1 PTPN13 FOXP3	1.35e-03	121	116	4	DOID:9256 (is_implicated_in)
Disease	head and neck squamous cell carcinoma (is_implicated_in)	JUNB PTPN13	1.56e-03	15	116	2	DOID:5520 (is_implicated_in)
Disease	Tinnitus	PTPN13 CDCA7 PKHD1 CACNA2D3	1.76e-03	130	116	4	HP_0000360
Disease	Early infantile epileptic encephalopathy with suppression bursts	CASK NEUROD2	1.77e-03	16	116	2	C0393706
Disease	lifestyle measurement, anxiety disorder measurement	FOXK2 CEBPA SORCS1 UNC5D	2.13e-03	137	116	4	EFO_0007795, EFO_0010724
Disease	asthma	FLG CEBPA DNAAF9 VWA7 FBLN2 NEUROD2 ZFP36L1 CDCA7 SRGAP3	2.90e-03	751	116	9	MONDO_0004979
Disease	disease of metabolism (implicated_via_orthology)	PFKL PFKM	3.06e-03	21	116	2	DOID:0014667 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	FLNB ABL1 APC2 GRIN2D TEK CIC SORCS1 FOXP4 FASN SRGAP3 FOXP3	3.42e-03	1074	116	11	C0006142
Disease	Ovarian Serous Adenocarcinoma	ERN1 TEK	3.67e-03	23	116	2	C1335177

Protein segments in the cluster

Peptide	Gene	Start	Entry
HPRTSGGTRGVLSGN	ACIN1	6	Q9UKV3
FPGISSTDRGGLRGH	PABPN1L	226	A6NDY0
STDRGGLRGHPGSRG	PABPN1L	231	A6NDY0
AFKGGGGPRSTHALD	BAHCC1	736	Q9P281
PTGASDHFLGRRGSP	BAHCC1	2111	Q9P281
SAFPREVGGAGAGLH	ADGRA2	756	Q96PE1
LADHAGSGRRSGPSP	CLK3	11	P49761
EGQDTIRGHPGSSRG	FLG	511	P20930
DGQDTIRGHPGSSRG	FLG	2781	P20930
GRSEPSAFLRGHGSR	DENND2B	261	P78524
SSRLLHQPGGGRGGE	DDN	516	O94850
DSPFNSDRGGRGHGL	DNAJB8	116	Q8NHS0
SGPDGATGRGQRIHL	RAB27A	56	P51159
SLFRGEHHSRGGTGR	RBM34	41	P42696
SHRGGELGISLRPDG	PBLD	256	P30039
TFGSGGHLSLGRLLA	CAPN15	856	O75808
RPSSGPGSGGHVFRS	ANKRD13B	571	Q86YJ7
SSFLEVRPDGHGGAR	ANKRD53	421	Q8N9V6
RAPGFGRSGGHSLSP	PODN	26	Q7Z5L7
ESGLVAGGRVGTPHF	CASK	171	O14936
FRAPSIHGGSGGRGV	KRT19	31	P08727
AHLAGEAGSRIPGLG	PNLIPRP3	171	Q17RR3
SLLTGGRPAGVHLSG	HLX	201	Q14774
AEGFRNTLRGLGTPH	LPAR5	301	Q9H1C0
PGGTFQGRDLRGGAH	FOXP3	41	Q9BZS1
SRRHLEIFTPPGGGG	FOXK2	76	Q01167
AGVGDRLGSSLRHGI	KCNK4	136	Q9NYG8
VGLGTESTGRGKPHF	GLB1L3	66	Q8NCI6
RGRGHVGSVLGGLAS	LMAN1L	116	Q9HAT1
TPGEGGEDTLGRRFH	ISLR	346	O14498
LAAGGHRGLDGLPTT	FBLN2	296	P98095
GPGLHGGIVGRSADF	FLNB	556	O75369
ASRRGTHGGLVTGLP	IRF2BPL	226	Q9H1B7
RLGFSVRGGSEHGLG	PDZD7	96	Q9H5P4
LGHVQRGGTPSAFDR	PFKL	296	P17858
LGHVQRGGTPSAFDR	PFKM	296	P08237
GGRTPHDLFSSGLFR	MEGF8	351	Q7Z7M0
APTVHGGAGGARISL	KRT23	31	Q9C075
TGSDPQSGLGRHLGV	LILRB2	446	Q8N423
RVHELSASGAPGRGG	KIF26A	1566	Q9ULI4
TFRIRLGAHRGGSGE	GDPD3	36	Q7L5L3
GLGSASLHGGGPARR	FOXP4	426	Q8IVH2
GHGPTVGLLLSRGAS	ANKRD65	346	E5RJM6
DHLRGQAGFFSTPGG	EXOC8	131	Q8IYI6
RVPHDLLGGSGGFTL	FAAP100	206	Q0VG06
SRDRGSLGHVTFGGL	ODAD1	551	Q96M63
RGGALLTSTSGPGFH	ERLIN2	36	O94905
AARAGPPGGRSLHSS	NDUFS8	16	O00217
SGDLGGKFSIHPRLG	DCHS2	916	Q6V1P9
RFEGGHGPSGAAIRF	PCF11	916	O94913
GLLGGGSVTPRVHSA	MAML2	21	Q8IZL2
HNAFRGGGSLPESLR	GALE	36	Q14376
HEGLGVAVGGFPASR	APC2	2246	O95996
HTGIGKRGLFGTRSS	DNAH6	151	Q9C0G6
VRVLPGGGAHGSTRD	KCNB1	841	Q14721
GSLPSQRGGRTGALH	CASC3	46	O15234
PSAAHQGRGGRSGLL	B3GNT4	6	Q9C0J1
GRHSFSRRSGVPGTE	ERN1	721	O75460
QGLRDARGGPSHSAG	ANKZF1	246	Q9H8Y5
GTPFSLGVALSRGHG	CACNA2D3	611	Q8IZS8
LGAAHPDLRASGGSG	CEBPA	256	P49715
TASHGAGGTGGRRLE	FNIP2	821	Q9P278
PRQAGHGGTATDTGR	LINC02875	216	Q86X59
FTSIHGRGGGALLGD	C1RL	261	Q9NZP8
GTGRRFLGGLLDHTS	AGBL4	381	Q5VU57
GHLVRSTGPGGSFAK	DNAAF9	311	Q5TEA3
GALRESGGSGFRSPH	ABL1	671	P00519
AGERGHLGSRGFPGI	COL27A1	1101	Q8IZC6
HPSELGGTRRAGNGA	MDFI	106	Q99750
SGRGGSRAGSQHLTP	MAP3K12	686	Q12852
SVGRSHALVYGPGGS	HOXC8	31	P31273
GFSQSHGGRPEAARL	ITGA10	256	O75578
CPTVSRSGGFFGHRG	CDC20B	476	Q86Y33
HGYATGRLAPGIRGS	KL	246	Q9UEF7
TFGRGDTGLGHRDSS	CYP4B1	196	P13584
GTGTPSLLRGKRGGH	EMID1	411	Q96A84
LAATTGPRAHIGGGA	CELSR3	46	Q9NYQ7
DRRSQGGPHLSGAVG	GRAP2	161	O75791
RPGETLLIHSGSGGV	FASN	1666	P49327
LVIRHGGAGGSPSVT	BICRA	1246	Q9NZM4
LLSSHRFSGAGSGGP	C1orf159	331	Q96HA4
LGSQHPFSAGGVGRS	SALL2	281	Q9Y467
SLPGSRGERPHSFGS	C8B	26	P07358
RVTGRGGLATFHGPG	LIPT2	81	A6NK58
RHISENSFGPSGGLR	PTPN13	1226	Q12923
RGTLAHAFAPGEGLG	MMP20	186	O60882
SGAASPGLFQAGHRR	NUMB	421	P49757
LHRAEASGGLGGLTR	TARS2	436	Q9BW92
HEPFRRGTGVDLGQG	RNF5	141	Q99942
LHAPDASGGCGGSRR	TMEM132E	236	Q6IEE7
LNGREHRSGEPVGSG	KCP	316	Q6ZWJ8
HGGTSYGRGIRVLPE	POT1	266	Q9NUX5
HGRGEAITLRFDGSP	SIPA1	651	Q96FS4
VSAGLRGSHGARGEP	SIRT3	46	Q9NTG7
HGGSLLTIEGTGLRG	PKHD1	1586	P08F94
GGTEGLLFVRHPDGR	ESRP2	386	Q9H6T0
FQGGHGPAATLLRRS	RIPK4	816	P57078
DRSLLGLGLPSGGFH	ARAP1	1286	Q96P48
GSFRGRHPLPGSDSQ	CDCA7	141	Q9BWT1
LHTVGGPGSARPRAF	CIC	341	Q96RK0
GPGSARPRAFSHSGV	CIC	346	Q96RK0
SSHRSRGVGGAVPGA	PKP3	256	Q9Y446
GGGFPRRHSVTLPSS	ZFP36L1	46	Q07352
RGHLVLTPFGIGDGR	ZNF48	591	Q96MX3
LAHSFLARRPGGTQG	TMEM143	371	Q96AN5
RRSGGDTHSPPRGLG	SRGAP3	866	O43295
SRLPAGTSGSRGHCG	RMDN1	21	Q96DB5
AHSIGALGPTGRGVV	SPTLC2	346	O15270
DLTTGRGRVGHGVPD	STOML1	331	Q9UBI4
GGSRRLSHSLGLPGG	PLCH2	1271	O75038
HSGPELQRTGRIFGG	SLC4A10	471	Q6U841
QARLGLGTEGSGRHG	SH2D7	251	A6NKC9
GEGHPGPVRRFTTAS	TEK	526	Q02763
ELRTTGVFGHLGGRL	UNC5D	541	Q6UXZ4
RGHLGNGDRPSAGAT	nan	66	Q8N1X5
SAEGGPTGLAHGRIS	ZNF503	271	Q96F45
LPSTRGGRRSGHGAV	nan	111	Q6ZS52
VASSHSPAGGFPRGR	nan	201	Q5PR19
HTTPVGDGAAGTRGL	TMEM41B	16	Q5BJD5
STPRGFSHQGRPGRA	SORCS1	51	Q8WY21
PLLLFSHREGGGRGA	nan	26	Q6ZS46
GGHFDRSSSQPPRGG	VWA7	246	Q9Y334
QEEGGGPLGHTRRFG	VWA7	551	Q9Y334
LAVGTGRFSGPLHRA	TMEM251	16	Q8N6I4
TATGYGRAPGGLSLH	JUNB	16	P17275
LHPGVSSRFSGRGSG	IGKV1D-42	76	A0A075B6H8
RPTGHGLVFGSSAVR	NEUROD2	336	Q15784
GHRGRTLGLGTGYRD	GRIN2C	1186	Q14957
RGGDLGTRRGSAHFS	GRIN2D	1316	O15399